Gout photo

Gout News

The latest Gout News articles published daily. Includes news on gout - a form of arthritis where sodium urate crystals form in joints from uric acid in the blood.

Add this Gout rss news feed to your rss reader:  View Our Gout XML Feed

Latest News

Clinical Trial Demonstrates That Rilonacept Significantly Reduces Gout Flares
09 January 2012
A phase II clinical trial found that rilonacept, an inhibitor of the protein interleukin-1 (IL-1), significantly reduced acute gout flares that occur when initiating uric acid-lowering therapy... [read article]

Gout Flares - Rilonacept Effective, According To Clinical Trial
06 January 2012
According to a phase II clinical trial, the drug rilonacept, which inhibits the protein interleukin-1 (IL-1), substantially reduces acute gout flares that occur at the start of uric acid-reducing therapy and is noted to be... [read article]

Regeneron Announces FDA Acceptance Of ARCALYST® (rilonacept) Supplemental Biologics License Application For Review
26 November 2011
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental Biologics License Application (sBLA) for ARCALYST Injection for... [read article]

Gout News Articles Archive  -   Page 1

09 November 2011

Preventing Gout Flare Ups In Patients With Renal Impairment - Dosing Guidance
07 November 2011

Gout Cases Missed By Traditional Tests Often Detected By CT Scans
American College Of Rheumatology 2011 Annual Meeting: Presentations By NYU Langone Experts
04 October 2011

Unsuitable Footwear Linked To Foot Impairment And Disability In Gout Patients
17 August 2011

Pegloticase, Alternative Treatment For Chronic Gout Shows Greater Improvement In Symptoms
New Drug Aids Gout Patients Not Helped By Standard Treatments
16 August 2011

Pegloticase Helps Patients With Severe, Chronic Gout
29 July 2011

Increase In Obesity And Hypertension Are Likely Contributors To The Increase In Gout Prevalence In US Over Last 2 Decades
28 July 2011

Got The Gout? Self Reported Cases Show Increase In Prevalence
04 June 2011

Lower Doses Of Anti-Gout Drug Recommended
27 May 2011

BioCryst Presents New Analyses Of BCX4208 Phase 2 Studies In Patients With Gout At The Annual European Congress Of Rheumatology
The True Burden Of Gout And Promising New Treatments
26 May 2011

Additional Results From A Phase 2b Study Of Lesinurad In Combination With Allopurinol
25 May 2011

Got The Gout? Novartis Sees Positive Results From Ilaris Treatment
19 May 2011

New Survey Reveals Most Americans Unaware Of Gout Risk Factors, In The Dark About Connection To Diabetes, Kidney Disease, And Cardiac Problems
18 April 2011

Teijin Pharma Expands Global Market For TMX-67 (febuxostat) - Turkey, Mexico, Caribbean, Middle East And North Africa
25 February 2011

Seniors Group Asks Medicare Part-D Plans To Provide Affordable Gout Medication For Patients
24 January 2011

TMX-67 (Febuxostat) Approved In Japan - Teijin-Developed Novel Drug For Chronic Management Of Hyperuricemia
19 January 2011

Uric Acid May Increase Likelihood Of Severe Osteoarthritis
10 December 2010

By 2019, The Acute Gout Drug Market Will Triple In Size While The Chronic Gout Drug Market Will Reach $1.83 Billion
09 December 2010

TreatmentTrends®: European Gout Study Highlights Current Treatment Patterns And Unmet Need For New Gout Therapies Among Rheumatologists
24 November 2010

TreatmentTrends®: Gout Study Highlights Differences In Clinical Management Of Gout Between Primary Care Physicians And Rheumatologists
23 November 2010

Fructose-Rich Beverages Associated With Increased Risk Of Gout In Women
10 November 2010

Drinks High In Fructose Raise Gout Risk For Women
BioCryst To Present New Data For BCX4208 Monotherapy At The 74th Annual American College Of Rheumatology (ACR) Scientific Meeting
09 November 2010

Hyperuricemia Rates Remain High Among U.S. Adults And Senior Citizens Placing Them At Risk For Developing Gout
The Number Of People With Gout Continues To Rise
Urate Lowering Therapy Could Prevent Death Associated With Cardiovascular Disease In People With Gout
Gout In Women, A Not So Sweet Outcome Of Sugar-Sweetened Drinks
Anti-Gout Drug May Decrease Risk For Colorectal Adenoma Progression
05 November 2010

Cegedim Strategic Data (CSD) Evaluates The Importance Of Cooperation Between GPs And Specialists For Gout Disease Management
27 October 2010

TMX-67 (ULORIC(r)) Launches In Canada - Novel Drug For Chronic Management Of Hyperuricemia In Gout Patients
05 October 2010

Nuon Therapeutics Announces Gout Program Study Results To Be Presented At The American College Of Rheumatology
03 October 2010

FDA Orders Halt To Marketing Of Unapproved Single-ingredient Oral Colchicine
19 September 2010

BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined With Allopurinol In Patients With Gout
15 September 2010

Krystexxa (pegloticase) Approved For Treatment Of Gout
14 September 2010

Arthritis Foundation And Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign
20 June 2010

Nuon Therapeutics Announces Positive Topline Results From A Phase 2a Study In Hyperuricemia
12 June 2010

Gout Drug Benefits Kidney Disease Patients
03 June 2010

BioCryst Initiates A Phase 2 Study Of BCX4208 Alone And In Combination With Allopurinol In Patients With Gout
02 May 2010

EnzymeRx Announces Strong Phase 1 Results For Pegsitacase
22 April 2010

Nuon Therapeutics Identifies Novel Use And Advances NU1618 Into Development For Chronic Hyperuricemia In Patients With Gout
01 April 2010

COLCRYS(R) (Colchicine, USP) Shows Superior Safety With Comparable Efficacy Compared To High-Dose Colchicine In Treatment Of Early Acute Gout Flares
31 March 2010

Savient Announces KRYSTEXXA(TM) Resubmitted BLA Accepted For Review By The FDA
30 March 2010

Gout Risk Factors For Women: Obesity, Hypertension, Alcohol And Diuretic Use
Molecular Prosthesis Against Gout
22 March 2010

Dual-Energy CT Accurately Diagnoses Gout In Acute, Emergency Settings
07 March 2010

Launch By Menarini And Ipsen Of ADENURIC(R) (febuxostat) In France For The Treatment Of Chronic Hyperuricemia In Gout
10 February 2010

Women With Gout At Greater Risk Of Heart Attack Than Men
08 January 2010

Ardea Biosciences Reports Positive Results For RDEA594, Its Lead Product Candidate For Gout, In Combination With Allopurinol Or Febuxostat
26 October 2009

Low-Dose Colchicine (Colcrys) Is Rapid, Effective Treatment For Acute Gout Flares
21 October 2009

Ardea Biosciences Announces Additional Positive Results From A Phase 2a Study Of RDEA594 At The 2009 ACR/ARHP Annual Scientific Meeting
For Management Of Hyperuricemia In Patients With Gout, Uloric (Febuxostat) Demonstrated Efficacy
20 October 2009

FDA Approves Colcrys(TM) (colchicine, USP) For Prevention Of Gout Flares
New Data Presented At ACR Meeting Demonstrates Colcrys(TM) (Colchicine, USP) Significantly Reduces Pain Of Acute Gout Flare Within 24 Hours
19 October 2009

ULORIC(R) (febuxostat) Demonstrated Efficacy For Management Of Hyperuricemia In Patients With Gout
13 October 2009

Rochester-Led Parkinson's Study Pays Off Again, 2 Decades Later
Go To News Page:
[1] 2 [Next] [Last Page]

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:


Gout

Most Popular Articles



Follow Our Gout News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Gout Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »